Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 1, 2010, Pages 9-16

  Zhao, Chunling ^a   Gong, Lei ^b   Li, Wentong ^a   Chen, Limei ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

ESCC; Migration; Overexpression; Plk1; Proliferation; Small interfering RNA

Indexed keywords

POLO LIKE KINASE 1; SMALL INTERFERING RNA;

ARTICLE; BIOASSAY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR DIFFERENTIATION;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 71449126696     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0630-4     Document Type: Article

References (29)

1. N Ahmad 2004 Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer FASEB J 18 5 7 10.1096/fj.03-0848hyp 10.1096/fj.03-0848hyp 14718382 (Pubitemid 38076461)
2. Y Bu Z Yang Q Li F Song 2008 Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells Oncology 74 198 206 10.1159/000151367 18714168
3. YB Feng DC Lin ZZ Shi XC Wang XM Shen Y Zhang, et al. 2009 Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma Int J Cancer 124 578 588 10.1002/ijc.23990 19004025
4. DM Glover IM Hagan AA Tavares 1998 Polo-like kinases: a team that plays throughout mitosis Genes Dev 12 3777 3787 10.1101/gad.12.24.3777 10.1101/gad.12.24.3777 9869630
5. E Kawata E Ashihara S Kimura K Takenaka K Sato R Tanaka, et al. 2008 Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer Mol Cancer Ther 7 2904 2912 10.1158/1535-7163.MCT-08-0473 10.1158/1535-7163.MCT-08-0473 18790771
6. R Knecht R Elez M Oechler C Solbach C von Ilberg K Strebhardt 1999 Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck Cancer Res 59 2794 2797 10383133
7. R Knecht C Oberhauser K Strebhardt 2000 PLK (polo-like kinase), a new prognostic marker for oropharyngeal carcinomas Int J Cancer 89 535 536 10.1002/1097-0215(20001120)89:6<535::AID-IJC12>3.3.CO;2-5 10.1002/1097-0215(20001120)89:6<535::AID-IJC12>3.0.CO;2-E 11102900
8. X Liu RL Erikson 2002 Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA Proc Natl Acad Sci USA 99 8672 8676 10.1073/pnas.132269599 12077309 (Pubitemid 34693618)
9. X Liu RL Erikson 2003 Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells Proc Natl Acad Sci USA 100 5789 5794 10.1073/pnas.1031523100 12732729 (Pubitemid 36576886)
10. AM Mandard P Hainaut M Hollstein 2000 Genetic steps in the development of squamous cell carcinoma of the esophagus Mutat Res 462 335 342 10.1016/S1383-5742(00)00019-3 10767643 (Pubitemid 30190239)
11. H Ohkura IM Hagan DM Glover 1995 The conserved Schizosaccharomyces pombe kinase plo1, required to form a bipolar spindle, the actin ring, and septum, can drive septum formation in G1 and G2 cells Genes Dev 9 1059 1073 10.1101/gad.9.9.1059 10.1101/gad.9.9.1059 7744248
12. YW Qian E Erikson FE Taieb JL Maller 2001 The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes Mol Biol Cell 12 1791 1799 11408585
13. A Rizki JD Mott MJ Bissell 2007 Polo-like kinase 1 is involved in invasion through extracellular matrix Cancer Res 67 11106 11110 10.1158/0008-5472.CAN-07-2348 18056432 (Pubitemid 350248532)
14. AK Roshak EA Capper C Imburgia J Fornwald G Scott LA Marshall 2000 The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase Cell Signal 12 405 411 10.1016/S0898-6568(00)00080-2 10.1016/S0898-6568(00)00080-2 11202906 (Pubitemid 30417604)
15. M Shirayama W Zachariae R Ciosk K Nasmyth 1998 The Polo-like kinase Cdc5p and the WD-repeat protein Cdc20p/fizzy are regulators and substrates of the anaphase promoting complex in Saccharomyces cerevisiae EMBO J 17 1336 1349 10.1093/emboj/17.5.1336 10.1093/emboj/17.5.1336 9482731 (Pubitemid 28105513)
16. B Spänkuch-Schmitt J Bereiter-Hahn M Kaufmann K Strebhardt 2002 Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells J Natl Cancer Inst 94 1863 1877 12488480
17. B Spänkuch-Schmitt G Wolf C Solbach S Loibl R Knecht M Stegmüller, et al. 2002 Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells Oncogene 21 3162 3171 10.1038/sj.onc.1205412 10.1038/sj.onc.1205412 12082631
18. GD Stoner A Gupta 2001 Etiology and chemoprevention of esophageal squamous cell carcinoma Carcinogenesis 22 1737 1746 10.1093/carcin/22.11.1737 10.1093/carcin/22.11.1737 11698334 (Pubitemid 33064837)
19. K Strebhardt L Kneisel C Linhart A Bernd R Kaufmann 2000 Prognostic value of pololike kinase expression in melanomas Jama 283 479 480 10.1001/jama.283.4.479 10.1001/jama.283.4.479 10659871
20. N Takai T Miyazaki K Fujisawa K Nasu R Hamanaka I Miyakawa 2001 Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage Cancer Lett 164 41 49 10.1016/S0304-3835(00)00703-5 10.1016/S0304-3835(00)00703-5 11166914 (Pubitemid 32144988)
21. N Takai T Miyazaki K Fujisawa K Nasu R Hamanaka I Miyakawa 2001 Polo-like kinase (PLK) expression in endometrial carcinoma Cancer Lett 169 41 49 10.1016/S0304-3835(01)00522-5 10.1016/S0304-3835(01)00522-5 11410324 (Pubitemid 32532095)
22. Y Tokumitsu M Mori S Tanaka K Akazawa S Nakano Y Niho 1999 Prognostic significance of polo-like kinase expression in esophageal carcinoma Int J Oncol 15 687 692 10493949
23. Toyoshima-Morimoto F, Taniguchi E, Shinya N, Iwamatsu A, Nishida E (2001) Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature 410: 215-220. doi: 10.1038/35065617 (Pubitemid 32216594)
24. Q Wang J Lu C Yang X Wang L Cheng G Hu, et al. 2002 CASK and its target gene Reelin were co-upregulated in human esophageal carcinoma Cancer Lett 179 71 77 10.1016/S0304-3835(01)00846-1 10.1016/S0304-3835(01)00846-1 11880184 (Pubitemid 34195655)
25. XQ Wang YQ Zhu KS Lui Q Cai P Lu RT Poon 2008 Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma Clin Cancer Res 14 6813 6820 10.1158/1078-0432.CCR-08-0626 18980975
26. G Wolf R Elez A Doermer U Holtrich H Ackermann HJ Stutte, et al. 1997 Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer Oncogene 14 543 549 10.1038/sj.onc.1200862 10.1038/sj.onc.1200862 9053852
27. Y Yamamoto H Matsuyama S Kawauchi H Matsumoto K Nagao C Ohmi, et al. 2006 Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer Oncology 70 231 237 10.1159/000094416 16837776 (Pubitemid 44154697)
28. J Yuan F Eckerdt J Bereiter-Hahn E Kurunci-Csacsko M Kaufmann K Strebhardt 2002 Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1 Oncogene 21 8282 8292 10.1038/sj.onc.1206011 10.1038/sj.onc.1206011 12447691 (Pubitemid 35477868)
29. J Zhou H Wang A Lu G Hu A Luo F Ding, et al. 2002 A novel gene, NMES1, downregulated in human esophageal squamous cell carcinoma Int J Cancer 101 311 316 10.1002/ijc.10600 10.1002/ijc.10600 12209954 (Pubitemid 34983185)